logo-loader

MetVital

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

MetVital is a clinical-stage, metabolic therapy company developing first-in-class, broadly applicable methods to improve cellular metabolism in diseases including Glioblastoma (brain cancer), Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease.